![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 17, 2004 9:31:26 AM
Cyclophosphamide has application in a number of cancers (including Ovarian and Breast Cancers) and it's rate of metabolism is highly variable amoung individual patients.
More interesting is the work on Taxanes with Johanthan Lancaster at Moffitt. I'm not certain how many here recognized that Taxane is a term that refers to the "group" of drugs that includes paclitaxel (Taxol) and docetaxel. Here's a little info for those interested:
http://www.hersource.com/breast/04/i1-pac.cfm
The fourth study proposal listed in the Moffitt Collaboration Agreement in the most recent 10Q is titled:
STUDY PROPOSAL ON TAXANES
PRINCIPAL INVESTIGATOR AT MOFFITT: JONATHAN M. LANCASTER, MD
Interesting..........
Later,
W2P
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM